-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Everolimus in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Everolimus in Epilepsy report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine...
-
Product Insights
Cortical Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Cortical Stimulators Pipeline Market Report Overview The cortical stimulator is a medical device. It is used to revive neural activity in the nervous system of critical patients by delivering an electrical shock using leads and electrode arrays implanted on the surface of the brain to induce brain activity. DBS devices send electrical stimulation through surgically-implanted electrodes to specific targets in the brain. The cortical stimulators pipeline market research report provides comprehensive information about the cortical stimulators pipeline products with a...
-
Company Profile
Surgalign Holdings Inc – Company Profile
Surgalign Holdings Inc (Surgalign), formerly RTI Surgical Inc, is a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products. The Spine Implants offers a wide range of cervical, thoracic, and lumbar interbody such as Fortilink cages with TETRAfuse and TiPlusTM technologies and supplemental fixation including, Streamline MIS or Degen or OCT pedicle screws and CervAlign ACDF plating system devices for customary spine fusion procedures, such as anterior cervical ciscectomy and fusion (ACDF), posterior cervical fusion...
Add to Basket -
Product Insights
Bone Grafts and Substitutes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Bone Grafts and Substitutes Pipeline Market Report Overview Bone grafts and substitutes are used in surgical procedures of bones in the human body. It is used in two cases either when there is a breakage in the bone or in the case of a void between or in the bones due to several factors such as age and degenerative diseases. Bone graft substitutes are synthetic substances that are an alternative to bone allografts and autografts. Allograft Bone Chips, Bone Morphogenetic...
-
Company Profile
BPH Energy Ltd – Company Profile
BPH Energy Ltd (BPH), is a stage funding, project management, and commercialization strategies provider. It carries out the development and commercialization of biomedical research and technologies, medical cannabis and oil and gas exploration. The company’s principal investment activities include: Cortical Dynamics Brain Anaesthesia Response (BAR) Monitor; Diagnostic Array Systems; HLS5. BPH has partnerships with various academic institutions and companies including The Western Australian Institute for Medical Research, Swinburne University of Technology, The Royal Melbourne Institute for Technology, Molecular Discovery Systems,...
Add to Basket -
Product Insights
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-Small Cell Lung Cancer Pipeline Drugs Market Report Overview Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. NSCLC (malignancy) originates in the tissues of the lungs or the cells lining the airways. Symptoms usually occur in the later stages of the disease, and include a persistent cough that may get worse over time, trouble breathing or shortness of breath, constant chest pain or discomfort, bloody phlegm or spit (sputum), fatigue and weakness, and unintentional weight...
-
Product Insights
Progressive Supranuclear Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Progressive supranuclear palsy, also called Steele-Richardson-Olszewski syndrome is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech and swallowing. Symptoms include fatigue, headaches, dizziness, depression, Parkinsonism, behavioral, cognitive, and gait disturbances that cause imbalance and arthralgias. The only proven risk factor for progressive supranuclear palsy is age. Treatment includes anticholinergic medications. The Progressive Supranuclear Palsy pipeline drugs market research report provides comprehensive information on the therapeutics under development for Progressive Supranuclear Palsy, complete with analysis by...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – everolimus
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry everolimus Drug Details Everolimus is under development for the treatment of intractable refractory epilepsy...
-
Product Insights
Net Present Value Model: Thiola/Thiola EC
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Thiola/Thiola EC Drug Details Tiopronin (Thiola)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AZD-0328
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AZD-0328 Drug Details AZD0328 is under development for the treatment of mild cognitive impairment...